- Home
- SBSI vs ALVO Comparison
SBSI vs ALVO Comparison
Compare SBSI & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SBSI | ALVO |
|---|---|---|
| Founded | 1960 | 2013 |
| Country | United States | Luxembourg |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 974.1M | 1.0B |
| IPO Year | 1995 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SBSI | ALVO |
|---|---|---|
| Price | $31.85 | $5.07 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $35.33 | $8.00 |
| AVG Volume (30 Days) | 115.7K | ★ 1.0M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | ★ 4.42% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.68 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $28.87 | $13.28 |
| Revenue Next Year | $5.82 | $18.63 |
| P/E Ratio | $19.08 | ★ $18.20 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $26.32 | $2.94 |
| 52 Week High | $36.20 | $9.25 |
Technical Indicators
Market Signals| Indicator | SBSI | ALVO |
|---|---|---|
| Relative Strength Index (RSI) | 40.79 | 80.25 |
| Support Level | $31.74 | $5.05 |
| Resistance Level | $33.37 | $5.46 |
| Average True Range (ATR) | 0.51 | 0.25 |
| MACD | -0.01 | 0.14 |
| Stochastic Oscillator | 34.77 | 98.26 |
Price Performance
Historical ComparisonAbout SBSI Southside Bancshares Inc.
Southside Bancshares Inc is a bank holding company. Through its subsidiary, it operates as a financial institution offering various financial services to individuals, businesses, municipal entities, and nonprofit organizations. These services include consumer and commercial loans, deposit accounts, wealth management and trust services, brokerage services, and safe deposit services. The company's primary market areas are East Texas, Southeast Texas, and the greater Dallas-Fort Worth, Austin, and Houston, Texas.
About ALVO Alvotech
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.